BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19913918)

  • 1. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
    Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
    J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity of hydrogen-bond-stabilized half-sandwich Ru(II) complexes with heterocycles.
    Mitra R; Das S; Shinde SV; Sinha S; Somasundaram K; Samuelson AG
    Chemistry; 2012 Sep; 18(39):12278-91. PubMed ID: 22903299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetranuclear coordination assemblies based on half-sandwich ruthenium(II) complexes: noncovalent binding to DNA and cytotoxicity.
    Linares F; Galindo MA; Galli S; Romero MA; Navarro JA; Barea E
    Inorg Chem; 2009 Aug; 48(15):7413-20. PubMed ID: 19586019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(3,5-Dibromo-4-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthrolinoruthenium(II) complexes: synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity.
    Liu YJ; Liang ZH; Li ZZ; Zeng CH; Yao JH; Huang HL; Wu FH
    Biometals; 2010 Aug; 23(4):739-52. PubMed ID: 20422275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
    Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
    J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium(II) arene anticancer complexes with redox-active diamine ligands.
    Bugarcic T; Habtemariam A; Deeth RJ; Fabbiani FP; Parsons S; Sadler PJ
    Inorg Chem; 2009 Oct; 48(19):9444-53. PubMed ID: 19780621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.
    Fernández R; Melchart M; Habtemariam A; Parsons S; Sadler PJ
    Chemistry; 2004 Oct; 10(20):5173-9. PubMed ID: 15372674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F
    Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
    Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
    Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Half-sandwich RuCl2(η(6)-p-cymene) core complexes containing sulfur donor aroylthiourea ligands: DNA and protein binding, DNA cleavage and cytotoxic studies.
    Jeyalakshmi K; Haribabu J; Bhuvanesh NS; Karvembu R
    Dalton Trans; 2016 Aug; 45(31):12518-31. PubMed ID: 27435011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of ruthenium(II) complexes and characterization of their cytotoxicity in vitro, apoptosis, DNA-binding and antioxidant activity.
    Liu YJ; Zeng CH; Liang ZH; Yao JH; Huang HL; Li ZZ; Wu FH
    Eur J Med Chem; 2010 Jul; 45(7):3087-95. PubMed ID: 20417586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinatively diverse ortho-phosphinoaniline complexes of ruthenium and isolation of a putative intermediate in ketone transfer hydrogenation catalysis.
    Hounjet LJ; Bierenstiel M; Ferguson MJ; McDonald R; Cowie M
    Inorg Chem; 2010 May; 49(9):4288-300. PubMed ID: 20364836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and reactivity of the ruthenium(II) dithiocarbonate complex [Ru(kappa2-S2C=O)(dppm)2] (dppm = bis(diphenylphosphino)methane).
    Wilton-Ely JD; Solanki D; Hogarth G
    Inorg Chem; 2006 Jun; 45(13):5210-4. PubMed ID: 16780346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
    Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands.
    Helena Garcia M; Morais TS; Florindo P; Piedade MF; Moreno V; Ciudad C; Noe V
    J Inorg Biochem; 2009 Mar; 103(3):354-61. PubMed ID: 19128838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.